ArticleHematology, transfusion and cell therapy

Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statement.

Margareth Castro Ozelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.